Italian U-turn ahead on medtech reference pricing
This article was originally published in Clinica
The Italian government has recognised the need to reassess its medtech supplies cost-containment strategy. Bowing to industry pressure, the parliament has approved a motion ordering the health ministry's medical devices commission (CUD) to identify alternatives to the pricing normalisation strategy launched last year. The government sees it as a matter of priority, and its significance cannot be overstated.